Skip to search formSkip to main contentSkip to account menu

Diabetic Neuropathies

Known as: Diabetic Neuropathies [Disease/Finding], DIABETIC NEUROPATHY, NEUROPATHY, DIABETIC 
Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic… 
National Institutes of Health

Related topics

Related topics

40 relations
CAPSICUM OLEORESINCapsaicinCapsaicin 0.25 MG/ML Topical CreamCapsicum extract

Broader (3)

Diabetes MellitusPeripheral Neuropathydiabetic peripheral neuropathy

Narrower (9)

Diabetic AmyotrophyDiabetic Asymmetric PolyneuropathyDiabetic Autonomic NeuropathyDiabetic Mononeuropathy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
Acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML), characterized by the t(15… 
Highly Cited
2010
Highly Cited
2010
Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF‐κB and Nrf2 cascades
Abstract:  Melatonin exhibits an array of biological activities, including antioxidant and anti‐inflammatory actions. Diabetic… 
Review
2008
Review
2008
Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.
OBJECTIVE To facilitate the clinician's understanding of the basis and treatment of painful diabetic neuropathy (PDN… 
Review
2004
Review
2004
Diabetic somatic neuropathies.
ropathic pain (7–10), and this and other putative mechanisms will be discussed. The clinical features, diagnosis, and management… 
Review
2004
Review
2004
Pregabalin relieves symptoms of painful diabetic neuropathy
Objective: Pregabalin, an alpha2-delta ligand with analgesic, anxiolytic, and anticonvulsant activity, has been evaluated for… 
Highly Cited
2002
Highly Cited
2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy…
BACKGROUND Diabetic dyslipidemia is characterized by high triglyceride levels; low high-density lipoprotein cholesterol levels… 
Highly Cited
2001
Highly Cited
2001
Reversal of experimental diabetic neuropathy by VEGF gene transfer.
The pathogenetic basis for diabetic neuropathy has been enigmatic. Using two different animal models of diabetes, we have… 
Highly Cited
1993
Highly Cited
1993
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
Beginning at the time of insulitis (7 wk of age), CD4+ and CD8+ mature thymocytes from nonobese diabetic (NOD) mice exhibit a… 
Highly Cited
1993
Highly Cited
1993
Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain
Review
1982
Review
1982
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)